trending Market Intelligence /marketintelligence/en/news-insights/trending/vnwxoxzszhb9_feaoixdmg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

NY fines EmblemHealth over gender reassignment surgery coverage issues

Infrastructure Issues: Tools to Dig Deep on Potential Risks

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

2018 US Property Casualty Insurance Market Report


Fintech Funding Flows To Insurtech In February

NY fines EmblemHealth over gender reassignment surgery coverage issues

EmblemHealth Inc. will pay $250,000 in civil penalties to New York State as part of a settlement that requires the health insurance company to cover gender reassignment surgery for its members.

An investigation by the New York State Office of the Attorney General found that EmblemHealth had a "deficient" process of updating criteria for gender reassignment surgery. The process included 2014 to 2017 guidelines that were "outdated" and "not medically accurate or evidence-based" during effective period.

The investigation also revealed the insurance company's "deficient" review of member requests, including coverage for mammoplasty as part of gender reassignment surgery. From January 2014 to July 2017, EmblemHealth denied 22 of 79 requests for pre-authorization of gender reassignment surgical procedures.

In accordance with the settlement, EmblemHealth updated its gender reassignment surgery guidelines. The company will also pay full restitution to members who paid out of pocket for the procedures after denial of coverage.